Back to Journals » Therapeutics and Clinical Risk Management » Volume 7
Original Research
Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,683 | Dovepress* | 11,483+ | 2,362 | 13,845 | |
PubMed Central* | 2,200 | 567 | 2,767 | ||
Totals | 13,683 | 2,929 | 16,612 | ||
*Since 9 August 2011 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar